Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | RICFY | TME |
|---|---|---|
| Price | $13.21 | $7.87 |
| Change today | ▼ 12.63% | ▲ 1.68% |
| Market cap | $12.39B | $12.39B |
| Return, 3 months | -10.0% | -8.7% |
| Return, year to date | -5.5% | -53.9% |
| Return, 1 year | -7.0% | -64.7% |
| P/E (TTM) | 19.1 | 9.2 |
| P/B | 4.5 | 1.1 |
| P/E percentile vs own 5y | – | 2nd |
| Dividend yield | 2.73% | 3.10% |
| Revenue growth (YoY, latest qtr) | – | +5.8% |
| Net profit growth (YoY) | – | +3.5% |
| Gross margin | – | 44.3% |
| Operating margin | – | 29.7% |
| Net margin | – | 26.3% |
| Return on equity | – | 11.0% |
| Analyst target vs. price | – | +63.8% |
| Analyst buy share | – | 57% |
| RSI (14) | 53 | 41 |
| 30-day volatility | 77.7% | 30.9% |
| Max drawdown, 1 year | -33.1% | -66.5% |
| Trend read | Leaning bearish | Strong downtrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
